Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
LNSR

LNSR - LENSAR, Inc. Stock Price, Fair Value and News

$12.35-0.13 (-1.04%)
Market Closed

16/100

LNSR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

16/100

LNSR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$10.01

Target 3M

$11.26

Target 6M

$10.63

LNSR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LNSR Price Action

Last 7 days

0.3%

Last 30 days

4.2%

Last 90 days

2.5%

Trailing 12 Months

11.0%

LNSR RSI Chart

LNSR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LNSR Valuation

Market Cap

147.5M

Price/Earnings (Trailing)

-2.86

Price/Sales (Trailing)

2.49

Price/Free Cashflow

-12.42

LNSR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$10.01

Target 3M

$11.26

Target 6M

$10.63

LNSR Fundamentals

LNSR Revenue

Revenue (TTM)

59.1M

Rev. Growth (Yr)

5.74%

Rev. Growth (Qtr)

2.73%

LNSR Earnings

Earnings (TTM)

-51.5M

Earnings Growth (Yr)

-147.2%

Earnings Growth (Qtr)

-110.49%

LNSR Profitability

Operating Margin

46.15%

Return on Equity

198.88%

Return on Assets

-73.39%

Free Cashflow Yield

-8.05%

LNSR Investor Care

Shares Dilution (1Y)

2.84%

Diluted EPS (TTM)

-4.4

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202557.1M58.4M59.1M0
202444.5M45.1M48.9M53.5M
202334.3M38.2M40.3M42.2M
202236.8M36.9M36.3M35.4M
202127.5M30.4M31.5M34.5M
202029.5M28.5M27.4M26.4M
201900030.5M
Get all data in R, Python etc through our Historical Stock Data APIs

About LENSAR, Inc.

LNSR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
 CEO
 WEBSITElensar.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES110

LENSAR, Inc. Frequently Asked Questions

LNSR is the stock ticker symbol of LENSAR, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of LENSAR, Inc. is 147.52 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check LNSR's fair value in chart for subscribers.

The fair value guage provides a quick view whether LNSR is over valued or under valued. Whether LENSAR, Inc. is cheap or expensive depends on the assumptions which impact LENSAR, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LNSR.

As of Wed Jan 28 2026, LNSR's PE ratio (Price to Earnings) is -2.86 and Price to Sales (PS) ratio is 2.49. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LNSR PE ratio will change depending on the future growth rate expectations of investors.